(2026). BAP1 Loss Might Be a Predictive Biomarker for Immunotherapy Response in Pleural Mesothelioma. Thoracic Cancer.
Successfully copied to clipboard
Copying to clipboard failed
Chicago Style (17th ed.) Citation
"BAP1 Loss Might Be a Predictive Biomarker for Immunotherapy Response in Pleural Mesothelioma."
Thoracic Cancer 2026.
Successfully copied to clipboard
Copying to clipboard failed
MLA (9th ed.) Citation
"BAP1 Loss Might Be a Predictive Biomarker for Immunotherapy Response in Pleural Mesothelioma."
Thoracic Cancer, 2026.
Successfully copied to clipboard
Copying to clipboard failed
Warning: These citations may not always be 100% accurate.